The FEI has announced two adverse analytical findings involving prohibited substances. One of them involves swiss showjumper Nadja Peter Steiner’s horse Saura de Fondcombe (by Balou du Rouet).
The cases involve the use of Ractopamine, and O-Desmethyltramadol, a metabolite of Tramadol which are *Banned Substances under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).
Horse: Saura De Fondcombe (FEI ID 103CM83/SUI)
Person Responsible: Nadja Peter Steiner (FEI ID 10006562/SUI)
Event: CSI3*-W – Tetouan (MAR) 05-08.10.2017
Prohibited Substance: O-Desmethyltramadol
Date of notification (9 November 2017)
The athletes listed have been provisionally suspended from the date of notification until the FEI Tribunal renders a decision. The horses, also listed, have been provisionally suspended for two months: